4.90
-0.03 (-0.61%)
| Previous Close | 4.93 |
| Open | 4.94 |
| Volume | 1,415,777 |
| Avg. Volume (3M) | 1,473,180 |
| Market Cap | 1,750,128,128 |
| Price / Earnings (TTM) | 70.00 |
| Price / Earnings (Forward) | 12.59 |
| Price / Sales | 2.39 |
| Price / Book | 2.67 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2025 - 11 Aug 2025 |
| Profit Margin | 3.57% |
| Operating Margin (TTM) | 13.69% |
| Diluted EPS (TTM) | 0.070 |
| Quarterly Revenue Growth (YOY) | 2.60% |
| Quarterly Earnings Growth (YOY) | -88.60% |
| Total Debt/Equity (MRQ) | 82.71% |
| Current Ratio (MRQ) | 5.22 |
| Operating Cash Flow (TTM) | 150.72 M |
| Levered Free Cash Flow (TTM) | 74.77 M |
| Return on Assets (TTM) | 4.26% |
| Return on Equity (TTM) | 4.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | GoodRx Holdings, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | 0.00 |
|
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 12.49% |
| % Held by Institutions | 62.94% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Francisco Partners Management, Lp | 31 Mar 2025 | 60,078,184 |
| Lakewood Capital Management, Lp | 31 Mar 2025 | 4,885,747 |
| Silver Lake Group, L.L.C. | 31 Mar 2025 | 3,532,276 |
| Petrus Trust Company, Lta | 31 Mar 2025 | 3,167,015 |
| Rip Road Capital Partners Lp | 31 Mar 2025 | 1,923,068 |
| Technology Crossover Management X, Ltd. | 31 Mar 2025 | 1,653,566 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 7.00 (Wells Fargo, 42.86%) | Buy |
| Median | 5.38 (9.80%) | |
| Low | 5.00 (Goldman Sachs, 2.04%) | Hold |
| Average | 5.69 (16.12%) | |
| Total | 1 Buy, 3 Hold | |
| Avg. Price @ Call | 4.40 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 13 May 2025 | 5.25 (7.14%) | Hold | 4.30 |
| Goldman Sachs | 09 May 2025 | 5.00 (2.04%) | Hold | 4.32 |
| Wells Fargo | 29 Apr 2025 | 7.00 (42.86%) | Buy | 4.66 |
| Truist Securities | 10 Apr 2025 | 5.50 (12.24%) | Hold | 4.32 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 10 Jun 2025 | Announcement | GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers |
| 09 Jun 2025 | Announcement | GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing |
| 05 Jun 2025 | Announcement | GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity |
| 22 May 2025 | Announcement | GoodRx to Launch Direct Contracting for Independent Community Pharmacies |
| 07 May 2025 | Announcement | GoodRx Reports First Quarter 2025 Results |
| 09 Apr 2025 | Announcement | GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call |
| 03 Apr 2025 | Announcement | GoodRx Introduces New E-commerce Experience for Retail Pharmacies |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |